Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,079 | 39,869 | N/A | N/A | N/A |
| TOTAL | $27,681 | $41,440 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,696 | 1,790 | N/A | N/A | N/A |
| Other Non-Current Assets | 4,014 | 5,404 | 0 | 0 | 0 |
| TOTAL | $5,710 | $7,194 | $N/A | $N/A | $N/A |
| Total Assets | $33,391 | $48,634 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 376 | 882 | 0 | 0 | 0 |
| Accrued Expenses | 9,417 | 6,940 | N/A | N/A | N/A |
| Other current liabilities | 661 | 5,712 | N/A | N/A | N/A |
| TOTAL | $10,454 | $13,534 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,454 | $13,534 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 861 | 527 | N/A | N/A | N/A |
| Common Shares | 77,156 | 76,550 | N/A | N/A | N/A |
| Retained earnings | -54,219 | -41,450 | N/A | N/A | N/A |
| TOTAL | $22,937 | $35,100 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $33,391 | $48,634 | $0 | $0 | $0 |